Stockreport

CytoDyn: Buy, Sell, Or Hold Following PRO 140 Commercial Agreement [Seeking Alpha]

CYTODYN INC  (CYDY) 
NASDAQ:AMEX Investor Relations: ir.cytodyn.com
PDF Summary CytoDyn recently announced Vyera Pharmaceuticals as the company's U.S. commercial partner for PRO 140 in HIV indications. As a result, the stock has doubled in v [Read more]